Abstract

The purified active fraction of Albizia julibrissin saponin (AJSAF) is an ideal adjuvant candidate that improves antigen-specific both cellular and humoral immune responses and elicits mixed Th1/Th2 responses, but its mechanisms remain unclear. The key features of action of AJSAF were investigated in mice immunized with Newcastle disease virus-based recombinant influenza vaccine (rL-H5) and AJSAF at the same leg (AJSAF+rL-H5) or different legs (AJSAF/rL-H5). The adjuvant activity of AJSAF on rL-H5 is strictly dependent on their spatial colocalization. Serum H5 antigen (H5Ag)-specific IgG, IgG1, IgG2a, and IgG2b antibody titers in AJSAF+rL-H5 group were significantly higher than those in AJSAF/rL-H5 group. The mechanisms of selectivity of Th1 or Th2 in mice induced by AJSAF was explored by the transcriptomic and proteomic profiles of H5Ag-stimulated splenocytes from the immunized mice using gene microarray and two-dimensional difference gel electrophoresis coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Compared to rL-H5 alone, AJSAF/rL-H5 induced more differentially expressed genes (DEGs) than AJSAF+rL-H5, whereas AJSAF+rL-H5 upregulated higher mRNA expression of Th1 (T-bet, IFN-γ, TNF-α, IL-12β, and IL-12Rβ1) and Th2 (IL-10 and AICDA) immune response genes. The neutrophil response and its derived S100A8 and S100A9 might be involved in the AJSAF-mediated Th1 response. Meanwhile, AJSAF might induce the adaptive immune responses by improving a local innate immune microenvironment. These findings expanded the current knowledge on the mechanisms of action of saponin-based adjuvants, and provided new insights into how adjuvants shape adaptive immune responses.

Highlights

  • Adjuvants are essential components of new generation vaccines

  • The mechanisms of action of Th1/Th2 responses induced by AJSAF were demonstrated based on the transcriptomic and proteomic profiles

  • S100A8 and S100A9 might involve in the Th1 response

Read more

Summary

Introduction

Adjuvants are essential components of new generation vaccines. Adjuvants augment the adaptive immune response to vaccines, and induce the most effective immune response types for specific pathogens. Th1 or Th2 responses generated upon antigenic stimulation can be modulated in vivo depending on the adjuvant used for immunization [1]. The Th1 immunity, correlated with the cellular immune response, is required for therapeutic cancer vaccines, as well as vaccines directed against intracellular pathogens such as viruses, certain bacteria, and parasite [2]. The Th2 immunity, which controls the humoral immune response, is effective for protection against extracellular pathogens including most bacteria and certain viruses [3]. The Th1/Th2 paradigm provides a useful model for understanding the mechanisms of adjuvant and the basis for the rational design of new adjuvants

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call